SCHEMBL30263307

SCHEMBL30263307

COCCOc1ccccc1-c1csc(-c2nc(C)ccc2C(N)=O)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.42
C1S P09871 2/20 0.41
CYP1A1 P04798 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP1B1 Q16678 2/20 0.39
KDM4E B2RXH2 1/20 0.38
ATP4A P20648 2/20 0.38
ATP4B P51164 2/20 0.38
SREBF2 Q12772 1/20 0.38
EIF4E P06730 3/20 0.37
HPGDS O60760 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CAPN1 P07384 1/20 0.36
GSTO1 P78417 1/20 0.35
P2RX3 P56373 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30263259 0.88 CYP19A1 (0.48) CYP19A1C1SCYP1A1CYP1A2CYP1B1
SCHEMBL30263223 0.79 KDM4E (0.51) CYP19A1C1SCYP1A1CYP1A2CYP1B1
SCHEMBL30263257 0.79 EIF4E (0.46) CYP19A1C1SEIF4ENPC1RAB9A
SCHEMBL30263311 0.77 JAK2 (0.48) CYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL30292519 0.71 CHEK2 (0.38) C1SEIF4ENPC1RAB9ASMN1; SMN2
SCHEMBL29695142 0.71 PARP1 (0.53) KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL24107419 0.71 KDM4E (0.52) KDM4EATP4AATP4BHPGDSNPC1
SCHEMBL30263180 0.69 PARP1 (0.40) KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL22728617 0.68 LMNA (0.59) KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL23835432 0.68 LMNA (0.67) KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161921-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF Anima Biotech Inc. (US) 2023-04-12 EP disclosed
CN-115916776-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2023-04-04 CN disclosed